Juvenile primary Sjögren's Syndrome: Cohort study
Keywords:
Sjögren syndrome, autoimmune disease, salivary glandsAbstract
Objective: To describe the demographic, clinical, and laboratory characteristics and management of patients with primary Sjögren syndrome.
Methods: Retrospective analysis of a cohort of 26 patients through review of medical records during the period February 2002 to December 2012.
Results: 26 patients diagnosed with juvenile SS were selected: 20 girls (76 %) and 6 children (23 %) with an average of 12 years. The clinical characteristics were mumps as the initial manifestation of the disease in 8 patients (30.7 %), and recurrent episode in 2 patients (7.6 %). 10 patients (38 %) had xerostomia and 16 (61 %) xerophthalmia. The Schirmer test was altered in 9 patients (34 %), Rose Bengal in 10 (38 %). 73 % of patients had altered scintigraphy. In 8 patients (30 %) the salivary gland biopsy revealed Sjögren syndrome. 8 patients (30 %) FR-positive, 10 patients (38 %) anti-Ro/SSA, 9 patients (34 %) anti-La/SSB,18 patients (69 %) ANA. 50% received glucocorticoid. Hydroxychloroquine was the drug most often used in 25 patients (96 %), followed by methotrexate and folic acid in 12 patients (46 %), azathioprine 4 patients (15.3 %) and cyclophosphamide in 2 patients (7.6 %). Only one patient required the use of human immunoglobulin and one leflunomide (3.8 %). Two patients (7.6 %) received rituximab.
Conclusions: The present study demonstrated the demographic, clinical and therapeutic in a series of patients with primary Sjögren's syndrome youth, a relatively rare condition, presenting an overview of this population in our hospital.
Downloads
References
Jonsson R, Moen K, Vestrheim D, Szodoray P. Current issues in Sjogren’s syndrome. Oral Dis. 2002;8(3):130-40.
Anaya JM, Ogowa N y Talal N. Sjogren syndrome in childhood. J Rheum. 1995;22(6):1152-8.
Kassan SS, Moutsopoulos HM. Clinical manifestations and early diagnosis of Sjogren syndrome. Arch Intern Med. 2004;164(12):1275-84.
Heart-Holmes M, Bathge BA, Abreo F, Wolf RE. Autoimmune endocrinopathy presenting as recurrent parotiditis of childhood. Arch Otolaringol Head Neck Surg. 1993;119:347-9.
Tapinos NI, Polihronis M, Tzioufas Ag, Moutsopoulos HM. Sjögren’s Syndrome. Autoimmune epithelitis. Adv Exp Med Biol 1999;455:127-34.
Robert I Fox. Sjögren’s síndrome. Lancet. 2005;366:321-31.
Correa P y Anaya JM. Imunogenética del Sindrome de Sjogren. En Anaya JM, Ramos M, Garcia M (eds.). 1 ed. Medellin: Ed. Corporación para investigaciones biológicas: 2001. p. 104-12.
Roser Solans M, Labrador J, Bosch A. Etiopatogenia del síndrome de Sjögren. Rev Esp de Medicina Clínica. 2001;19(116):750-5.
Kalk WW, Mansour K, Vissink A, Spijkervet FK, Bootsma H, Kallenberg CG, et al. Oral and ocular manifestations in Sjogren’s syndrome. J Rheumatol. 2002;29(5):924-30.
Bell M, Askari A, Bookman A, Frydrych S, Lamont J, Mccomb J et al. Sjögren’s syndrome: a critical review of clinical management. J Rheumatol. 1999;26:2051-61.
Borges C, Sousa R. Atualização em síndrome de Sjögren. Rev Bras Reumatol. 2005;45(5):323-6.
Nikitakis N, Rivera H, Lariccia C, Papadimitriou J, Sauk J. Primary Sjogren syndrome in childhood: Report of a case and review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2003;96:42-7.
Daniels T: Sjogren's syndrome: clinical spectrum and current diagnostic controversies. Adv Dent Res 1996;10(1):3-8.
Skopouli FN, Dafni U, Ioannidis JPA, Moutsopoulos HM. Clinical evolution, and morbidity and mortality of primary Sjögren’s syndrome. Semin Arthritis Rheum 2000;29:296-304.
Barile Fabris L, Xibille Friedmann D. Síndrome de Sjögren. Rev Mex de Reumatología. 2003;18(2):137-46.
Stiller M, Golder W, Dbring E, Biedermann T. Primary and secondary Sjogren's Syndrome in children: A comparative study. Clin Oral Investig 2000; 4:176-82.
Locht H, Pelck R, Manthorpe R. Clinical manifestations correlated to the prevalence of autoantibodies in a large (n = 321) cohort of patients with primary Sjogren's syndrome. A comparison of patients initially diagnosed according to the Copenhagen classification criteria with the American-European consensus criteria. Autoimmun Rev. 2005;4:276-81.
Asmussen KH, Bowman SJ. Outcome measures in Sjogren’s syndrome. Rheumatology (Oxford). 2001;40(10):1085-8.
Vitali C, Bonbardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE et al. European Study Group on Classification Criteria for Sjögren’s Syndrome. Classification criteria for Sjogren’s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis. 2002;61(6):554-8.
Vitali C, Bombardieri S, Moutsopoulos HM, Balestrieri G, Bencivelli W, Bernstein RM et al. Preliminary criteria for Sjögren’s Syndrome. Results of a prospective concerted action supported by the European Community. Arthritis Rheum. 1993;36:340-7.
Hara T, Nagfata M, Mizuno Y, Ura Y, Matsuo M, Ueda K. Recurrent parotid swelling in children: clinical features useful for differential diagnosis of Sjogren síndrome. Acta paediatr. 1992;81:547-9.
Sheppard JD. Guidelines for the treatment of chronic dry eye disease. Manag Care. 2003;12 Suppl. 12:20-5.
Fox RI, Michelson P. Approaches to the treatment of Sjogren’s syndrome. J Rheumatol. 2000;61 Suppl. 1:15-21.
Fox RI. Sjogren’s syndrome: current therapies remain inadequate for a common disease. Expert Opin Investig Drugs. 2000;9(9):2007-16.
Neira G, Méndez P, Rodríguez C, Rojas T. parotiditis crónica recurrente o síndrome de sjögren primario juvenil? reporte de un caso. Rev chil pediatr. 2009;80(4):361-66.
Marmor D, Pinto A: Recurrent parotid enlargement as an initial manifestation of Sjogren's syndrome in children: A case report. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2004;97:459.
Cimaz R, Casadei A, Rose C, Bartunkova J, Sediva A, Falcini F et al. Primary Sjogren síndrome in the paediatric age: a multicentre survey. Eu J Pediatr. 2003; 162(10):661-65.
Kobayashi I, Furuta H, Tame A. Complications of childhood Sjogren syndrome. Eur j Pediatr. 1996; 155:890-94.
StillerM, Golder W, Dbring E, Biedermann T. Primary and secondary Sjogren's Syndrome in children: A comparative study. Clin Oral Investig 2000; 4:176-82.
Ohtsuka T, Saito Y, Hasegawa M. Central nervous system disease in a children with primary Sjogren síndrome. J Pediatr. 1995; 127:961-63.
Bartunková J, Sedivá A, Vencovsky J, Tesar V. Primary Sjögren’s syndrome in children and adolescents proposal for diagnostic criteria. Clin Exp Rheumatol 1999; 17(3):381-6.
Chudwin DS, Daniels TE, Wara DW Ammann AJ, Barrett. DJ, Whitcher JP, et al. Spectrum of Sjogren Syndrome in children. J Pediatr: 1981; 98:213-7.
Published
How to Cite
Issue
Section
License
Warning of rights of author
The authors that publish in this journal agree with the following terms:
The authors conserve the rights of author and concede to the journal the right of the first publication, fulfilling with the license Creative Commons Attribution License that allows to others share the work with recognition of the authorship of their articles, and the initial publication in this journal.
The authors can establish separately additional agreements for the no exclusive distribution of the version of the work published in the journal (for example, situate it in an institutional repository, in a personal blog or publish it partial or totally in a book), with a recognition of their initial publication in this journal.
To be able to send the manuscript or part of him passed three months of published, for his evaluation to other publishers, identifying it or not with the same title; whenever allusion is made to our journale and know it the new publisher.
The publishing committee of the Cuban Journal of Rheumatology authorizes to other publishers, to reproduce the articles published in our magazine, whenever it indicate the origin of the same.
The authors should send a document in Office Word application format through the electronic address of the magazine with a similar format to that we include next:
---------------------------------------------------------------------------------------------------------------------
Statement of authorship and cede of articles for the publication of the scientific work in the Cuban Journal of Rheumatology
Date:
Those who subscribe certify that are the authors of the work:
Of this form communicate the originality of our article clearing that the concepts and knowledges of other authors that have included in the text of the article, have been quoted properly in the bibliography.
We do proof besides that the article in question is original and has not been published, total neither partially, in another journal.
To be approved for his publication in the Cuban Journal of Rheumatology, do secession of the rights of publication to the same one through the method that realizes it usually.
In front of any catchword that exist by the article that send to evaluate, relieve of of the responsibility to the Cuban Journal of Rheumatology holding us responsible with all the difficulties that can berelated by any situation.
We include to continuation the name and the signature of all authors and collaborators of this article.
Name: Signature:
